Compare
Cooper Companies (The) vs Haemonetics (COO vs HAE)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Cooper Companies (The) (COO) returned -9.5% and Haemonetics (HAE) +136.5%; so far this year the figures are -23.9% and +49.6%.
Cooper Companies (The) is the larger company by market value, about 2.2 times the size of Haemonetics.
On trailing earnings, COO trades at 21.4 times and HAE at 53.1 times.
Revenue grew +4.7% at COO and +4.1% at HAE over the last year.
Data as of the latest close. Not investment advice.
Relative performance
| COO | HAE | |
|---|---|---|
| Price | $62.36 | $119.93 |
| 1-day | -1.81% | -3.37% |
| YTD | -23.91% | +49.63% |
| 1 year | -9.47% | +136.46% |
| 3 years | -21.29% | +38.82% |
| Market cap | $11.9B | $5.5B |
| P/E | 21.4 | 53.1 |
| P/S | 2.80 | 3.95 |
| P/B | 1.42 | 6.08 |
| Revenue growth | +4.70% | +4.10% |
| EPS growth | +43.10% | -33.90% |
| Gross margin % | 65.9 | 59.6 |
| Net margin % | 13.5 | 7.5 |
| ROE % | 6.8 | 11.6 |
| Debt / equity | 0.31 | 1.25 |
| FCF yield % | 5.7 | 5.5 |
| Dividend yield % | — | — |
| Beta | 0.47 | 0.14 |
| RSI (14) | 58.1 | 55.5 |
| Technical rating |